These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31842556)

  • 1. Inflammatory myofibroblastic tumor of the uterus - case report.
    Štiková Z; Ptáková N; Horáková M; Kosťun J; Ondič O
    Cesk Patol; 2019; 55(4):239-243. PubMed ID: 31842556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors.
    Ptáková N; Miesbauerová M; Kosťun J; Grossmann P; Šidlová H; Pavelka J; Presl J; Alaghehbandan R; Bouda J; Ondič O
    Virchows Arch; 2018 Nov; 473(5):583-590. PubMed ID: 30116888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
    Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
    Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
    Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
    Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
    Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
    Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.
    Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH
    Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
    Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
    J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
    Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH
    Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review.
    Zhang L; Luan L; Shen L; Xue R; Huang J; Su J; Huang Y; Xu Y; Wang X; Shao Y; Ji Y; Xu C; Hou Y
    Virchows Arch; 2023 Mar; 482(3):567-580. PubMed ID: 36624188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.
    Carballo EV; Pham TV; Turashvili G; Hanley K; Starbuck KD; Meisel JL
    Gynecol Oncol Rep; 2022 Oct; 43():101062. PubMed ID: 36032811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.
    Schaefer IM; Hornick JL; Sholl LM; Quade BJ; Nucci MR; Parra-Herran C
    Histopathology; 2017 Jun; 70(7):1138-1146. PubMed ID: 28130839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine inflammatory myofibroblastic tumor.
    Karpathiou G; Devouassoux-Shisheboran M; Stolnicu S; Chauleur C; Péoc'h M
    Pathol Res Pract; 2023 Feb; 242():154335. PubMed ID: 36706588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report.
    Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors.
    Devereaux KA; Kunder CA; Longacre TA
    Am J Surg Pathol; 2019 Jan; 43(1):64-74. PubMed ID: 29794871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors.
    Devins KM; Samore W; Nielsen GP; Deshpande V; Oliva E
    Mod Pathol; 2023 Jun; 36(6):100143. PubMed ID: 36806735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel CASC15-ALK and TFG-ROS1 Fusion Observed in Uterine Inflammatory Myofibroblastic Tumor.
    Chang B; Wang Z; Ren M; Yao Q; Zhao L; Zhou X
    Int J Gynecol Pathol; 2023 Sep; 42(5):451-459. PubMed ID: 36730016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring
    Zhao T; Zhang X; Liu X; Ren M; Cheng Y; Wang J; Luo Z
    Front Oncol; 2023; 13():1147974. PubMed ID: 37035208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.